# Diabetes, Insulin, Gut, Enteric Supplementation Trial

> **NCT07682077** · NA · RECRUITING · sponsor: **University of New Brunswick** · enrollment: 60 (estimated)

## Conditions studied

- Gestational Diabetes Mellitus (GDM)
- Blood Glucose
- Insulin Resistance, Diabetes
- Gut Microbiome
- Gut Metabolites

## Interventions

- **DIETARY_SUPPLEMENT:** Kefir

## Key facts

- **NCT ID:** NCT07682077
- **Lead sponsor:** University of New Brunswick
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-06-01
- **Final completion:** 2029-06-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07682077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07682077, "Diabetes, Insulin, Gut, Enteric Supplementation Trial". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07682077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*